Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0E2ZA
|
|||
| Former ID |
DIB016116
|
|||
| Drug Name |
PPC-5650
|
|||
| Indication | Pain [ICD-11: MG30-MG3Z] | Phase 1 | [1] | |
| Company |
Antalium Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Acid-sensing ion channel 1 (ASIC1) | Target Info | Modulator | [1] |
| KEGG Pathway | Inflammatory mediator regulation of TRP channels | |||
| Reactome | Stimuli-sensing channels | |||
| WikiPathways | Iron uptake and transport | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01449487) Investigation of Efficacy and Safety of PPC-5650 to Experimental Induced Sensation and Pain in the Rectosigmoid. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.